To evaluate the feasibility of robot-assisted single-port (SP) transvesical partial prostatectomy (TVPP) using a novel purpose-built SP surgical platform in a pre-clinical model.
Introduction
Prostate cancer (PCa) is the most common malignancy among men in the western world [1] . Organ-confined PCa treatment relies on precise evaluation of the primary disease site. With the evolution of technology, prostate imaging techniques, such as MRI, are being used to localize PCa lesions, which has had a dramatic impact on the management of this urological malignancy [2] . MRI studies have shown that anterior prostate cancers (APCs) account for~21% of all prostate malignancies [3, 4] . Standard treatment for these lesions includes radical whole-gland surgery or radiotherapy, which are associated with substantial side effects such as urinary incontinence (5-20%) and erectile dysfunction (30-70%). Robot-assisted laparoscopic surgery and energy-based ablation therapy for localized PCa do not necessarily offer improvements in patient morbidity and health-related quality-of-life outcomes. Surgical removal of the APCs, for example, by partial prostatectomy, has been proposed as an alternative treatment for energy-based ablation of localized PCa. In a recent study, Villers et al. [5, 6] . reported on a case series of patients with low-and intermediate-risk PCa who underwent robot-assisted anterior partial prostatectomy, with excellent functional outcomes. The modern era of PCa surgery has been mainly driven by the development of novel minimally invasive techniques, such as laparoendoscpic single-site surgery (LESS) and natural orifice transluminal endoscopic surgery (NOTES) [7] . Improvements in these surgical techniques boost the evolution of novel robotic platforms, such as the SP1098 (Intuitive Surgical, Sunnyvale, CA, USA) that may potentially facilitate earlier postoperative recovery, reduced pain and improved cosmesis. This surgical platform merges the concept of LESS with robotics, providing the basis for performing intraluminal reconstructive, ablative and extirpative procedures using single-port (SP) access. Robot-assisted LESS offers the possibility of new surgical approaches, such as transvesical, that were technically challenging in prostate cancer surgery with standard robotic platforms. The objective of the present study was to evaluate the feasibility of robot-assisted SP transvesical partial prostatectomy (TVPP) using a novel purpose-built SP surgical platform (SP1098) in a pre-clinical model.
Materials and Methods

Features of the Da Vinci SP1098 Surgical System
The new da Vinci SP1098 consists of a surgeon console, vision cart and patient side cart, similar to da Vinci's previous surgical platforms (SP999). A single arm is connected to the patient side cart and consists of four instruments, including three robotic instruments and an articulating camera, which are inserted through a 25-mm SP multichannel port. Additional characteristics include the SP1098 EndoWrist instruments (maintaining the seven degrees of freedom with an additional 'elbow' joint to facilitate SP intracorporeal triangulation), high-definition three-dimensional optics, an instrument guidance system, and enhanced instrument arm control. The console is similar to the previous generations of da Vinci systems, with an integrated separate foot clutch allowing simultaneous movements of the instruments and cameras.
Surgical Technique
We operated on three cadavers, placed in a lithotomy position. A 3-cm midline incision was made in the suprapubic area 4-cm from the symphisis pubis. After opening the Retzius space, the bladder was distended via a catheter, and a GelPOINT (Applied Medical, Rancho Margarita, CA, USA) was introduced percutaneously into the bladder (Fig. 1 ). An SP multichannel port was inserted through the GelSeal cap to accommodate an oval articulating camera (12 mm 9 10 mm) and three 6-mm double-jointed articulating instruments (Fig. 2 ). An 8-mm accessory port was used for introduction of sutures and suctioning. The operating table was placed at 0 degrees and the SP robotic platform was side-docked ( Fig. 3) . Pneumovesicum was obtained providing an adequate space for robotic arm mobilization. After docking the da Vinci robotic system, all the SP-TVPP steps performed were similar in the three cadavers.
Step 1: Antegrade Dissection at the Bladder Neck An incision was made distal to the trigone to expose the peripheral zone of the prostate and avoid the ureteric orifices. Dissection was performed circumferentially around the bladder neck.
After exposing the transition zone of the prostate, a combination of blunt and sharp dissection was continued; the plane between the seminal vesicles and Denonvilliers fascia was developed. Dissection was carried anteriorly through the anterior commissure of the prostate. The dorsal venous complex marked the anterior limit of resection. In the cadaver model, a hypothetical clinical scenario was created of a unifocal anterior tumour localized to the medial prostaterequiring wedge resection. The anterior prostate was divided along the prostatic urethra. Resection of the tumour was started at the 10 and 2 o'clock positions with cold scissors using an anterograde approach and incising the transition zone up to the verumontanum. The verumontanum and the posterior half of the urethra were preserved, completing the resection of the anterior tumour from our hypothetical case.
Step 2: Bladder Reconstruction to the Urethra Vesico-prostato-urethra anastomosis was performed by approximating the edges of the bladder neck and advancing the anterior bladder flap to the urethral stump. Reconstruction was started by suturing the urethral stump to the prostatic urethral plate using a 3-0 barbed (length 30.48 cm) running suture. Then, the proximal prostatic urethral plate was advanced to the anterior bladder neck. Once half of the urethra was approximated, the anterior urethral stump was sutured to the bladder neck. Lastly, the posterior bladder flap was sutured to the edge of the initial bladder neck incision obtaining a watertight anastomosis (Fig. 4) .
The SP robot was undocked, the gelseal was opened and the specimen was extracted from the incision (Fig. 5) . A singlelayer watertight closure was used to approximate the bladder using a 3-0 running (length 15.24 cm) barbed suture. In this pre-clinical study, the primary outcomes were completion of SP-TVPP without conversion, total robot operating time, and intra-operative complications (any accidental puncture or laceration to an organ, hollow viscus or blood vessel).
Results
The three procedures were technically successful through the transvesical route. The mean total operation duration was 49.3 min, the mean time to obtain transvesical access was 16 min, and the mean anastomotic suturing time was 14.3 min. There appeared to be no undue tension on the vesicoprostatic-urethral anastomotic suture line. There was no need for conversion to standard techniques, or for additional ports. In this pre-clinical model, there were no intra-operative complications. A summary of the steps and operating times is given in Table 1 .
Discussion
Over recent years, there has been an enormous expansion in the use of minimally invasive surgery for treating organconfined PCa. Robot-assisted urological surgery has been shown to be a safe surgical system for numerous urological procedures.
In the present study, we have shown the feasibility of a purpose-built, novel robotic platform in performing SP-TVPP. This technique is proposed as an alternative to standard treatment on a very selected population for removal FEET HEAD Recently, focal ablative therapy (high-intensity focused ultrasonography, cryotherapy or laser ablation) has been proposed as an alternative therapy for particular PCa lesions, with the aim of preserving quality of life for the patient. To the best of our knowledge, there are no current data supporting the safe utilization of focal therapy specifically in APC. Robot-assisted partial prostatectomy is a surgical concept that was initially proposed by Villers et al. [5, 6] in a carefully chosen group of patients with APC. The technique was feasible in 17 consecutive patients with low-to intermediate-risk APC who were enrolled in a well-designed prospective single-arm phase study. Short-term oncological outcomes showed an APC recurrence-free survival at 2 years of 0.86 (95% CI 0.55-0.96), with continence and potency rates of 100% and 83%, respectively [6] .
With advances in robot-assisted surgery, a new SP1098 robotic platform was developed to enhance the LESS approach. Fusion of robotic technology into the LESS space was initially evaluated by Kaouk et al. [8] , who described the first series of clinically applicable SP robotic surgery and reported favourable outcomes.
The unique aspects of this SP platform prompted us to further extend the scope of minimally invasive surgery and explore the possibility of performing partial prostatectomy via a transvesical approach.
During the cadaver procedure, we recognized several advantages of the SP transvesical approach compared with a conventional three-arm transperitoneal robotic approach. Achieving access through a suprapubic incision with the mini advance access platform (GelPOINT) is technically simple and avoids the risks inherent to intraperitoneal access, such as accidental visceral puncture. In addition, transvesical access avoids the need for steep Trendelenburg positioning, which after extended periods of time is associated with rhabdomyolysis, positioning injuries and facial/laryngeal oedema [9, 10] . After the SP system is docked, the SP cannula is positioned inside the bladder, providing an acceptable pneumovesicum owing to the effective seal from the multiaccess platform. With sufficient bladder distention and the ergonomic design of the SP1098 EndoWrist instruments, there is an ideal surgical space for intracorporeal triangulation, making anterior resection of the prostate feasible. Moreover, the pneumoperitoneum is bypassed with the transvesical approach, excluding the possible deleterious effects of CO 2 absorption on the cardiopulmonary physiology of patients.
Additionally, the SP three-dimensional high-definition magnified vision allows the surgeon to differentiate the surgical planes to achieve resection of an anterior lesion. An adequate urethro-prostato-vesical anastomosis can satisfactorily be completed with triangulation of the robotic instruments and precise EndoWrist movement facilitated by the 'elbow' joint.
Limitations of the present study include the preclinical model and lack of a control group. Additionally, certain technical aspects of the SP-TVPP still need to be considered because this was a cadaver model and the ability to perform haemostasis was not feasible. The ability to increase pneumovesicum with no impact on cardiopulmonary variables may in fact facilitate haemostasis, especially if suture ligation of the dorsal venous complex is required. Furthermore, this was a proof-of-concept study, conducted by an experienced robotic surgery team with a small sample size, which makes intra-operative complications difficult to assess. As with other surgical procedures, SP-TVPP is not without risk, and it is mandatory that the occurrence of complications in humans be evaluated.
In conclusion, we demonstrated the technical feasibility of SP-TVPP in human cadavers. The clinical applicability of this novel approach in selected patients with low or intermediaterisk organ-confined APC is imminent.
